Judy Kirk

5.6k citations

107 papers · 3.1k indexed · h-index 30

Impact in

Genetics top 1%
- BRCA gene mutations in cancer
Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research

Papers in

Genetics 61
- BRCA gene mutations in cancer 58
Cancer Research 22
- Cancer Genomics and Diagnostics 19

Co-authors: Kathy Tucker Bettina Meiser Phyllis Butow Gillian Mitchell Scott Edmands Eileen Bryant Graeme Suthers Elizabeth Lobb
Journals: Familial Cancer (6 papers)Gynecologic Oncology (4 papers)European Journal of Human Genetics (3 papers)Journal of Renal Nutrition (3 papers)Cancer Epidemiology Biomarkers & Prevention (3 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Judy Kirk

103 papers receiving 3.0k citations

Peers

Countries citing papers authored by Judy Kirk

Since Specialization

Citations

This map shows the geographic impact of Judy Kirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy Kirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy Kirk more than expected).

Fields of papers citing papers by Judy Kirk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy Kirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy Kirk. The network helps show where Judy Kirk may publish in the future.

Co-authors

The 25 scholars most cited alongside Judy Kirk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Judy Kirk Line = papers co-authored together Judy Kirk links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma Translational Oncology ·Omali Pitiyarachchi, Yeh Chen Lee, Hao‐Wen Sim, Sivatharsny Srirangan, Cristina Mapagu, Judy Kirk, Paul R. Harnett, Rosemary L. Balleine, David D.L. Bowtell, Goli Samimi, Alison H. Brand, Deborah J. Marsh, Philip Beale, Lyndal Anderson, Natalie Bouantoun, Pamela Provan, Susan J. Ramus, Anna DeFazio, Michael Friedländer	2023	0
2	Mainstream genetic testing for high‐grade ovarian, tubal and peritoneal cancers: A tertiary referral centre experience Australian and New Zealand Journal of Obstetrics and Gynaecology ·Shweta Srinivasa, Michelle Bowman, Leanna Titterton, Paul R. Harnett, Alison H. Brand, Judy Kirk, Abiramy Ragunathan	2023	3
3	“Out of the blue”: A qualitative study exploring the experiences of women and next of kin receiving unexpected results from BRA‐STRAP research gene panel testing Journal of Genetic Counseling ·April Morrow, Catherine Speechly, Alison L. Young, Kathy Tucker, Rebecca Harris, Nicola Poplawski, Lesley Andrews, Tu Nguyen Dumont, Judy Kirk, Melissa C. Southey, Amanda Willis	2023	0
4	What’s in a Name? Parents’ and Healthcare Professionals’ Preferred Terminology for Pathogenic Variants in Childhood Cancer Predisposition Genes Journal of Personalized Medicine ·Jacqueline Hunter, Eden G. Robertson, Kate Hetherington, David S. Ziegler, Glenn M. Marshall, Judy Kirk, Jonathan M. Marron, Avram Denburg, Kristine Barlow‐Stewart, Meera Warby, Kathy Tucker, Brittany M. Lee, Tracey O’Brien, Claire E. Wakefield	2022	4
5	Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics Familial Cancer ·(unknown), Bettina Meiser, Rajneesh Kaur, Judy Kirk, April Morrow, Michelle Peate, WK Wong, E. McPike, Elisa J. Cops, Cassandra B Dowson, Rachel Austin, Miriam Fine, Letitia Thrupp, Robyn L. Ward, Finlay Macrae, Janet E. Hiller, Alison Trainer, Gillian Mitchell	2020	13
6	Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma European Journal of Human Genetics ·Amelia K. Smit, Ainsley J. Newson, Megan Best, Caro‐Anne Badcock, Phyllis Butow, Judy Kirk, Kate Dunlop, Georgina Fenton, Anne Ε. Cust	2018	16
7	Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals? British Journal of Dermatology ·Amelia K. Smit, Louise Keogh, Ainsley J. Newson, Phyllis Butow, Kate Dunlop, Rachael L. Morton, Judy Kirk, D. Espinoza, Anne Ε. Cust	2017	13
8	A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public Cancer Epidemiology Biomarkers & Prevention ·Amelia K. Smit, David Espinoza, Ainsley J. Newson, Rachael L. Morton, Georgina Fenton, Lucinda Freeman, Kate Dunlop, Phyllis Butow, Matthew H. Law, Michael G. Kimlin, Louise Keogh, Suzanne Dobbinson, Judy Kirk, Peter A. Kanetsky, Graham J. Mann, Anne Ε. Cust	2016	34
9	Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial Genetics in Medicine ·Veronica Quinn, Bettina Meiser, Judy Kirk, Kathy Tucker, Kaaren Watts, Belinda Rahman, Michelle Peate, Christobel Saunders, Elizabeth Geelhoed, Margaret Gleeson, Kristine Barlow‐Stewart, Michael Field, Marion Harris, Yoland Antill, Linda Cicciarelli, Philip Crowe, Michael T. Bowen, Gillian Mitchell	2016	26
10	Exploring clinicians’ attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer Familial Cancer ·Yanni Chen, Michelle Peate, Rajneesh Kaur, Bettina Meiser, Tim Wong, Judy Kirk, Robyn L. Ward, Annabel Goodwin, Finlay Macrae, Janet E. Hiller, Alison H. Trainer, Gillian Mitchell	2016	6
11	Message From the Chairperson: Focus on Professional Involvement Journal of Renal Nutrition ·Judy Kirk	2015	1
12	Health professionals’ evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer Familial Cancer ·Kirsten F. L. Douma, Bettina Meiser, Judy Kirk, Gillian Mitchell, Christobel Saunders, Belinda Rahman, Mariana S. Sousa, Kristine Barlow‐Stewart, Margaret Gleeson, Kathy Tucker	2014	12
13	Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling? Genetics in Medicine ·Elvira Zilliacus, Bettina Meiser, Elizabeth Lobb, Patrick J. Kelly, Kristine Barlow‐Stewart, Judy Kirk, Alan D. Spigelman, Linda Warwick, Kathy Tucker	2011	60
14	Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers Cancer Epidemiology Biomarkers & Prevention ·Yoland C. Antill, Gillian Mitchell, Sandra Johnson, Lisa Devereux, Alvin Milner, Juliana Di Iulio, Geoffrey J. Lindeman, Judy Kirk, Kelly‐Anne Phillips, Ian Campbell	2010	22
15	Breast cancer immunohistochemistry can be useful in triage of some HNPCC families Familial Cancer ·Susan Shanley, CHAK-HEI FUNG, J. Milliken, James F. Leary, Rebecca A. Barnetson, Mark A. Schnitzler, Judy Kirk	2009	19
16	Attitudes Toward Genetic Testing for Cancer Risk after Genetic Counseling and Decision Support: A Qualitative Comparison between Hereditary Cancer Types Genetic Testing ·Claire E. Wakefield, Nadine A. Kasparian, Bettina Meiser, Judi Homewood, Judy Kirk, Kathy Tucker	2007	9
17	Estimating the referral rate for cancer genetic assessment from a systematic review of the evidence British Journal of Cancer ·C. Featherstone, Andrew Colley, Kathy Tucker, Judy Kirk, Michael Bartoň	2007	12
18	A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk Breast Cancer Research and Treatment ·Claire E. Wakefield, Bettina Meiser, Judi Homewood, Michelle Peate, Alan Taylor, Elizabeth Lobb, Judy Kirk, Mary‐Anne Young, Rachel Williams, Tracy Dudding, Kathy Tucker, (unknown)	2007	65
19	Value of PCR analysis for long term survivors after allogeneic bone marrow transplant for chronic myelogenous leukemia: a comparative study Leukemia & lymphoma ·Régis Costello, Judy Kirk, Jean Gabert	1996	16
20	Multiplex PCR of bcr-abl fusion transcripts in Philadelphia positive acute lymphoblastic leukemia. Genome Research ·A Yeong Lee, Judy Kirk, Scott Edmands, Jerald P. Radich	1995	15

About Judy Kirk

Judy Kirk is a scholar working on Genetics, Cancer Research, Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Oncology, having authored 107 papers that have together received 3.1k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (58 papers), Genetic factors in colorectal cancer (19 papers), Cancer Genomics and Diagnostics (19 papers), Family Support in Illness (10 papers), Prenatal Screening and Diagnostics (9 papers), Global Cancer Incidence and Screening (9 papers), Colorectal Cancer Screening and Detection (8 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). The work is most often cited by research in Genetics (1.3k citations), Hematology (505 citations), Cancer Research (554 citations), Pathology and Forensic Medicine (614 citations) and Oncology (826 citations). Judy Kirk has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Kathy Tucker, Bettina Meiser, Phyllis Butow, Gillian Mitchell, Scott Edmands, Eileen Bryant, Graeme Suthers, Elizabeth Lobb, Ted Gooley and Peter S. Kessler. Their work appears in journals such as Familial Cancer, Gynecologic Oncology, European Journal of Human Genetics, Journal of Renal Nutrition and Cancer Epidemiology Biomarkers & Prevention.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact